1-8 of 8
Lisa La, MS
Close
Sort by
Journal Articles

Phase 1 Study of Elotuzumab in Combination with Autologous Stem Cell Transplantation and Lenalidomide Maintenance for Multiple Myeloma

Keren Osman, MD, Ajai Chari, MD, Samir Parekh, MD, Christine Pun, BS, Gillian Morgan, RN, Erika Florendo, ANP-BC, Elaine Chan, BS, Marisa Shields, Gina Strumolo, MA, Lisa La, MS/CCRP, John Mandeli, PhD, James Geerlof, BS, PA, Sundar Jagannath, MD, Hearn Jay Cho, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3448.
https://doi.org/10.1182/blood.V128.22.3448.3448
Published: 2016
Journal Articles

A Phase II Study of Pomalidomide, Daily Low Dose Oral Cyclophosphamide, and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MD, Hearn Jay Cho, MD PhD, Samir Parekh, MD, Kenneth Lau, Gillian Morgan, RN, Donna Catamero, ANP-BC, Melissa Cortes, AGPCNP-BC, Meredith Curtis, AGPCNP-BC, Juliet Escalon, NP, Erika Florendo, ANP-BC, Daniel Verina, ACNP-BC, Nadege Stevens, RN, Elaine Chan, BS, Katarzyna Garcia, MS / CCRP, Lisa La, MS/CCRP, Marisa Shields, Gina Strumolo, MA, Sundar Jagannath, MD
Journal: Blood
Blood (2016) 128 (22): 4520.
https://doi.org/10.1182/blood.V128.22.4520.4520
Published: 2016
Journal Articles

A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

Ajai Chari, MD, Hearn Jay Cho, MD PhD, Siyang Leng, MD, Amishi Dhadwal, BS, Gillian Morgan, Lisa La, MS/CCRP, Katarzyna Garcia, MS / CCRP, Crystle Carter, RN, Donna Catamero, Juliet Escalon, Erika Florendo, Nadege Stevens, RN, Daniel Verina, Moon-hee Yum, RN, Jude Gullie, BA, Elaine Chan, BS, Sundar Jagannath, MD, Violetta V Leshchenko, PhD, Alessandro Lagana, PhD, Jingjing Qi, Manishkumar Patel, Kim-Schulze Seunghee, Samir Parekh, MD
Journal: Blood
Blood (2015) 126 (23): 4226.
https://doi.org/10.1182/blood.V126.23.4226.4226
Published: 2015
Journal Articles

Recapturing Disease Response: A Phase II Study of High Dose Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma Who Have Progressed on Standard Dose Carfilzomib

Ajai Chari, MD, Hearn Jay Cho, MD PhD, Samir Parekh, MD, Keren Osman, MD, Talia Goldstein, BA, Gillian Morgan, Lisa La, MS/CCRP, Crystle Carter, RN, Donna Catamero, Juliet Escalon, Daniel Verina, Erika Florendo, Moon-hee Yum, RN, Nadege Stevens, RN, Jude Gullie, BA, Elaine Chan, BS, Sundar Jagannath, MD
Journal: Blood
Blood (2015) 126 (23): 3051.
https://doi.org/10.1182/blood.V126.23.3051.3051
Published: 2015
Journal Articles

A Phase II, Single-Center, Open-Label Study of Oral Panobinostat in Combination with Lenalidomide and Weekly Dexamethasone in Patients with Multiple Myeloma

Ajai Chari, MD, Hearn J. Cho, MD PhD, Samir Parekh, MD, Amishi Dhadiwal, Katarzyna Garcia, MS, Natalie Belostotsky, Donna Catamero, NP, Arlynn Brion, Lauren Cardone, Juliet Escalaon, Daniel Verina, Moon-hee Yum, Lisa La, MS, Jude Gullie, BA, Elaine Chan, BS, Sundar Jagannath, MD
Journal: Blood
Blood (2014) 124 (21): 3486.
https://doi.org/10.1182/blood.V124.21.3486.3486
Published: 2014
Journal Articles

A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat In Combination With Lenalidomide and Weekly Dexamethasone In Patients With Multiple Myeloma

Noa Biran, MD, Samira Shahnaz, MD, Sundar Jagannath, MD, Hearn J. Cho, MD, PhD, Keren Osman, MD, Samir Parekh, MD, Danielle Choi, RN, Katarzyna Garcia, MS, Donna Catamero, NP, Lisa La, MS, Jude Gullie, BA, Elaine Chan, BS, Ajai Chari, MD
Journal: Blood
Blood (2013) 122 (21): 5392.
https://doi.org/10.1182/blood.V122.21.5392.5392
Published: 2013
Journal Articles

The Multiple Myeloma Research Consortium (MMRC): Accelerated Start up and Accrual Metrics Speeds Drug Development

Sandra M. Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MD, Mark Fiala, BS, Sagar Lonial, MD, Alaina R. Mitchell, BS, David S. Siegel, MD, PhD, Adolfo Aleman, CCRP, Andrzej J Jakubowiak, MD, PhD, Diane E Durecki, BA, Donna E. Reece, MD, FRCPC, Engin Gul, HonBSc, Ajai Chari, MD, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Mindy A Bowers, BS, A. Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Geraldine Pelle-Day, Ph.D., Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Daniel Larsen, BS, Shaji Kumar, MD, Ann Birgin, CRA, Noopur S. Raje, MD, Vivek Roy, M.D., Michele Maharaj, RN, Joseph W. Fay, MD, Tracey Messing, RN, Robert F Ott, MBA, Leah Tasca, BA, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2011) 118 (21): 1024.
https://doi.org/10.1182/blood.V118.21.1024.1024
Published: 2011
Journal Articles

The Multiple Myeloma Research Consortium (MMRC) Model: Reduced Time to Trial Activation and Improved Accrual Metrics.

Sandra Wear, RN, Paul G. Richardson, MD, Carolyn Revta, MPH, Ravi Vij, MBBS, MD, Mark Fiala, BS, CCRP, Sagar Lonial, MD, Dixil Francis, MPH, CCRC, David Samuel diCapua Siegel, MD, PhD, Alex Schramm, BA, Andrzej J. Jakubowiak, MD, PhD, Colleen K. Harvey, Donna E. Reece, MD, Engin Gul, HonBSc, Sundar Jagannath, MD, Lisa La, MS, Craig C. Hofmeister, MD, Buffy Jansak, BSN, OCN, Keith Stewart, MBA, MB, CHB, Rachel Hagerty, Jeffrey L. Wolf, MD, Beth Davis, Amrita Krishnan, MD, Lupe Duarte, CCRC, Todd M. Zimmerman, MD, Angela Cisneros, Shaji Kumar, MD, Ann Birgin, CRA, Robert Ott, MBA, Leah Tasca, Susan L. Kelley, MD, Kenneth C. Anderson, MD, Kathy Giusti, MBA
Journal: Blood
Blood (2010) 116 (21): 3803.
https://doi.org/10.1182/blood.V116.21.3803.3803
Published: 2010